Moderna | MRNA - Operating Expenses


Moderna reported $1.18B in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
Acadia Pharmaceuticals USD 270.57M 450K Sep/2026
Agios Pharmaceuticals USD 155.3M 24.53M Jun/2026
Alnylam Pharmaceuticals USD 1.11B 52.78M Sep/2026
Amgen USD 5.69B 6B Sep/2026
Arrowhead Research USD 245.35M 30.35M Jun/2026
Biogen USD 2.32B 663.6M Sep/2026
BioMarin Pharmaceutical USD 819.04M 5.5B Sep/2026
Celltrion KRW 133.99B 14.77B Jun/2026
Cspc Pharmaceutical CNY 5.91B 512.77M Dec/2025
Deva Holding AS TRY 1.35B 178.26M Sep/2023
Dianthus Therapeutics USD 62.24M 15.25M Jun/2026
Divis Laboratories Ltd INR 22.52B 3.01B Sep/2026
Gilead Sciences USD 13.04B 9.09B Sep/2026
GlaxoSmithKline GBP 6.03B 227M Sep/2026
Incyte USD 5.64B 4.67B Sep/2026
Ionis Pharmaceuticals USD 373M 2.76M Sep/2026
Kangmei Pharma CNY 1.22B 130.32M Jun/2026
Knight Therapeutics CAD 126.9M 8.29M Dec/2025
Laboratorios Farma EUR 313.62M 17.98M Dec/2023
Malin Corporation EUR 1.1M 400K Dec/2024
Moderna USD 1.18B 223M Sep/2026
Organigram Holdings CAD 100.45M 30.86M Jun/2026
Ovoca Bio EUR 173K 990K Dec/2025
Pharma Mar EUR 46.77M 4.24M Sep/2026
Puma Biotechnology USD 49.26M 3.2M Jun/2024
Qiagen NV USD 393.64M 17.95M Jun/2026
Regeneron Pharmaceuticals USD 33.5B 1.79B Sep/2026
Sangamo BioSciences USD 33.87M 12.89M Jun/2024
Sarepta Therapeutics USD 390.39M 2.43M Sep/2026
Sartorius EUR 746.5M 1.3M Sep/2026
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
Tilray USD 237.52M 17.34M Sep/2025
Ultragenyx Pharmaceutical USD 283M 6M Sep/2026
United Therapeutics USD 6.28B 124.3M Sep/2026
Vertex Pharmaceuticals USD 2.18B 118.2M Sep/2026
Zealand Pharma A/S 573M 202.97M Mar/2026
Zz Pientze Pharmaceu CNY 1.54B 90.74M Sep/2026